VANCOUVER, Aug. 25, 2014 /PRNewswire/ - YOLO Medical Inc., ("YOLO") an industry leader in medical and aesthetic device manufacturing and distribution, announced today that it has commenced legal action for patent infringement.
A lawsuit was filed on August 19, 2014 by YOLO Medical Inc. with the California Central District Court against the following for patent infringement: Chromogenex Technologies Ltd., Chromogenex US, Inc., Strawberry – Laser Lipo Ltd., Lilia Enterprises, LLC., Lipolaser Centers of America, One Source Media, Brandon Robinson, Jon Perlman, M.D., David Halpern, M.D., Leonard Grossman, M.D., Stephen Ronan, M.D., F.A.C.S. and VB Laser Trim Clinic.
"This is an unfortunate, yet necessary action that we must undertake in order to protect our customers, our intellectual property, our brand, our technology, and years of work and dedication that YOLO has invested in establishing itself and its technology" states Robert J. Krznaric, President and CEO of YOLO Medical Inc. "YOLO is a leader in the development of innovative medical and aesthetic technologies, and with that comes a responsibility to protect our legal rights. Staying true to our corporate mission, we at YOLO recognize our responsibility in representing and protecting our loyal customers." "As a Canadian Company, we are placing our trust in the U.S. Patent System to protect our innovations."
About YOLO Medical Inc.
YOLO Medical Inc. - a company devoted to real technology, real science and real results. YOLO is a leader in the aesthetics industry with a global distribution footprint. YOLO's technology enables physicians to provide advanced solutions for medical-aesthetic applications, including body contouring, treatment of cellulite and pain management. The company's commitment to innovation expands throughout North America, Europe and Asia. Founded in 2003, the corporate, R&D, and manufacturing headquarters for YOLO Medical Inc. are located in British Columbia, Canada.
Additional information can be found at www.yolomedical.com.
|SOURCE YOLO Medical Inc.|
Copyright©2014 PR Newswire.
All rights reserved